Cargando…
Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway
PURPOSE: Gastric cancer (GC) has high morbidity and mortality and is a serious threat to public health. The flavonoid compound vitexin is known to exhibit anti-tumor activity. In this study, we explored the therapeutic potential of vitexin in GC and its underlying mechanism. MATERIALS AND METHODS: T...
Autores principales: | Zhou, Peng, Zheng, Zi-Han, Wan, Tao, Wu, Jie, Liao, Chuan-Wen, Sun, Xue-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Gastric Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753280/ https://www.ncbi.nlm.nih.gov/pubmed/35079445 http://dx.doi.org/10.5230/jgc.2021.21.e40 |
Ejemplares similares
-
Erratum: Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway
por: Zhou, Peng, et al.
Publicado: (2022) -
Vitexin suppresses renal cell carcinoma by regulating mTOR pathways
por: Li, Yuhong, et al.
Publicado: (2020) -
Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
por: Wang, Haiyong, et al.
Publicado: (2016) -
VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
por: Pu, Zhangya, et al.
Publicado: (2022) -
CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR
por: Wang, Luben, et al.
Publicado: (2022)